Lo's Lab Readies T21 Test for Hong Kong, Looks to Additional Sequencing-based Prenatal Dx | GenomeWeb

By Monica Heger

This story was originally published Nov. 20.

HONG KONG — The Chinese University of Hong Kong plans to launch a noninvasive, sequencing-based Down syndrome test for high-risk pregnancies in Hong Kong in the next one to two months. Longer term, it is aiming to develop prenatal targeted sequencing-based tests to diagnose beta-thalassemia and other genetic diseases.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.